Neurodevelopmental Disorders

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

3 weeks ago talkbio0Tagged BMB-101, BMB-105, Bright Minds Biosciences, Clinical Trials, Neurodevelopmental Disorders, Prader-Willi Syndrome, PWS, Scientific Advisory Board

Bright Minds Biosciences; Scientific Advisory Board; Prader-Willi Syndrome; PWS; BMB-101; BMB-105; clinical trials; neurodevelopmental disorders

Fierce Biotech Fundraising Tracker ’25: Grin Raises $140M Series D and Strikes Major Angelini Deal; Syndeio Secures $90M

7 months ago talkbio0Tagged Angelini Pharma, Blackstone Life Sciences, Grin, Neurodevelopmental Disorders, pharma partnerships, radiprodil, Series D financing, Syndeio

Grin Therapeutics; Series D financing; radiprodil; Angelini Pharma; Blackstone Life Sciences; Syndeio; biotech fundraising; neurodevelopmental disorders; pharma partnerships

Sage Therapeutics Rejects Biogen’s Acquisition Proposal, Remains Open to Future Deals

11 months ago talkbio0Tagged Acquisition, Biogen, Depression, Postpartum, Neurodevelopmental Disorders, Neuropsychiatry, proposal - intent, Zurzuvae

Sage Therapeutics, Biogen, Acquisition Proposal, Postpartum Depression, ZURZUVAE, Neurodevelopmental Disorders, Neuropsychiatry